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Abstract
Author Manuscript

Maternal asthma and air pollutants have been independently associated with preeclampsia but
rarely studied together. Our objective was to comprehensively evaluate preeclampsia risk based on
the interaction of maternal asthma and air pollutants. Preeclampsia and asthma diagnoses,
demographic and clinical data came from electronic medical records for 210,508 singleton
deliveries. Modified Community Multiscale Air Quality models estimated preconception, first and
second trimester and whole pregnancy exposure to: particulate matter (PM) < 2.5 and < 10 µm,
ozone, nitrogen oxides (NOx), sulfur dioxide (SO2) and carbon monoxide (CO); PM2.5
constituents; volatile organic compounds (VOCs) and polycyclic aromatic hydrocarbons (PAHs).
Asthma-pollutant interaction adjusted relative risks (RR) and 95% confidence intervals (CI) for
preeclampsia were calculated by interquartile range for criteria pollutants and high exposure (≥
75th percentile) for PAHs and VOCs. Asthmatics had higher risk associated with first trimester
NOx and SO2 and whole pregnancy elemental carbon (EC) exposure than non-asthmatics, but only
EC significantly increased risk (RR=1.11, CI:1.03–1.21). Asthmatics also had a 10% increased
risk associated with second trimester CO. Significant interactions were observed for nearly all
VOCs and asthmatics had higher risk during all time windows for benzene, ethylbenzene, mxylene, o-xylene, p-xylene and toluene while most PAHs did not increase risk.
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1. Introduction
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Ambient air pollution appears to increase the risk for hypertensive disorders of pregnancy
(Pedersen et al., 2014). Preeclampsia is new-onset hypertension, often with proteinuria,
diagnosed after 20 weeks of gestation. It is a serious complication of pregnancy associated
with preterm birth as well as substantial morbidity and mortality in mothers and infants
(Hutcheon et al., 2011). Recent meta-analyses found significant increased risks for
preeclampsia associated with particulate matter < 2.5 µm (PM2.5), nitrogen dioxide (NO2),
and traffic exposures, but no significant increased risk associated with nitrogen oxides
(NOx), particulate matter < 10 µm (PM10), carbon monoxide (CO) or ozone (O3) (Pedersen
et al., 2014). Maternal asthma has also been associated with preeclampsia in a recent metaanalysis (Murphy et al., 2011), and in our data, we previously observed a 14% increase in
the adjusted odds of preeclampsia in singleton pregnancies complicated by maternal asthma
(Mendola et al., 2013).

Author Manuscript

Asthma is common among women of reproductive age (Moorman et al., 2012). While air
pollution can exacerbate asthma (Guarnieri and Balmes, 2014), only one prior study
examined the interaction of asthma and air pollutants, looking exclusively at first trimester
exposure to NOx and O3. Olsson et al. (2013). This Swedish register-based study found no
relation between preeclampsia and NOx and no significant interactions for O3 and asthma in
the risk for preeclampsia. Our aim was to examine whether the relationships between
preeclampsia and criteria air pollutant exposures as well as exposure to high levels of
polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs) were
different among women with and without asthma, for exposures preconception and
throughout pregnancy, in a large contemporary U.S. obstetric cohort.

2. Materials and methods
2.1. Study population

Author Manuscript

Our study is based on a retrospective cohort of 228,438 births at ≥ 23 weeks gestation
assembled using hospital delivery admission electronic medical records (both mother and
neonate charts) from 12 centers (19 hospitals; 15 hospital referral regions) across the United
States (Zhang et al., 2010). We excluded multi-fetal pregnancies (n=5053), pregnancies
missing air quality data (n=10) or maternal age (n=307), women with chronic hypertension
(n=4358) and superimposed preeclampsia (n=1889) because they were not at risk for newonset hypertension. We also excluded women with gestational hypertension (n=6074) or
eclampsia (n=239) to allow comparison of preeclampsia cases to a normotensive reference
group. This resulted in an analytic sample of 210,508 singleton pregnancies among 192,687
women. Most women (175,700; 91.1%) contributed only one pregnancy. All participating
institutions in the Consortium on Safe Labor, noted in the acknowledgements, received
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institutional review board approval for the study. All records are anonymized and individual
patient consent was not required.
2.2. Outcome and covariates

Author Manuscript

Both preeclampsia and maternal asthma diagnoses were indicated in the electronic records
and/or in the maternal discharge summary using International Classification of Diseases,
Ninth Revision (ICD-9) diagnostic codes. The specific gestational age at preeclampsia
diagnosis was not available, but severity of preeclampsia was distinguished using ICD-9
codes (642.4: mild or unspecified preeclampsia; 642.5: severe preeclampsia). Asthma
diagnosis was recorded in the medical record and/or in the discharge summary (ICD-9 code
493.0–493.9). Maternal age (continuous), race/ethnicity (White, Black, Hispanic, Asian/
Pacific Islander, Other/Unknown), pre-pregnancy body mass index (BMI) category
(underweight < 18.5, normal weight 18.5 to < 25, overweight 25 to < 30, obese ≥ 30,
unknown), parity (nulliparous, primiparous, multiparous), marital status (married, divorced/
widowed, single, unknown), insurance status (public, private, other, unknown), smoking and
alcohol use during pregnancy (both yes/no) were all derived from the electronic medical
record.
2.3. Exposure

Author Manuscript

We estimated air pollutant exposures, both for criteria pollutants and hazardous air toxics,
using a modified version of the Community Multiscale Air Quality (CMAQ) model, which
is based on a three-dimensional, regional air quality model developed by the U.S.
Environmental Protection Agency (U.S. EPA). The model inputs weather data including
hourly measures of temperature, relative humidity and wind characteristics as well as air
pollutant emissions generated using the U.S. EPA National Emission Inventories. Hourly
exposures were calculated over the entire continental U.S. for the years 2001–2010 in the
Air Quality and Reproductive Health study which was completed in 2013 and described in
detail elsewhere (Chen et al., 2014). Briefly, model estimates for criteria air pollutants:
PM2.5, PM10, O3, NOx, sulfur dioxide (SO2) and CO were fused with monitor data from the
US EPA Air Quality System to correct for measurement errors using inverse distance
weighting to take advantage of measured data where they were available. Constituents of
PM2.5, polycyclic aromatic hydrocarbons (PAHs) and volatile organic compounds (VOCs)
were based on CMAQ model output since these pollutants are not routinely monitored. The
final model demonstrated improved performance in comparison with four other exposure
assessment strategies, including monitor data alone and raw CMAQ data (Chen et al., 2014).

Author Manuscript

Hourly exposure estimates were averaged across the delivery hospital referral region and
weighted for population density to estimate windows of exposure for each pregnancy as a
proxy for maternal residence and local mobility. The size of hospital referral regions ranged
from 415 to 312,644 square kilometers. The preconception window was an average of 90
days prior to the last menstrual period which was calculated based on the best obstetrical
estimate of gestational age. We also estimated the first and second trimester average (0 to <
14 gestational weeks and 14 to < 28 gestational weeks, respectively) and the whole
pregnancy average. Since preeclampsia is diagnosed after 20 weeks by definition, the
preconception and first trimester time windows will always precede diagnosis. Most
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pregnancies also have a full second trimester window. We included the whole pregnancy
time window to be comparable with other studies and because a preeclampsia diagnosis
triggers a medically-indicated delivery at or near term and expectant management will often
lead to delivery within 1–2 weeks (Magee et al., 2009; Koopmans et al., 2009). Accordingly,
whole pregnancy might be considered a proxy of an average exposure until diagnosis.
2.4. Statistical analyses

Author Manuscript

Pregnancy was the unit of analysis in all statistical testing. Frequency distributions of
pregnancies with and without asthma by preeclampsia status were calculated. Log linear
models, with generalized estimating equations to account for multiple births to the same
mother, were used to calculate the relative risk and 95% confidence intervals for
preeclampsia. Interaction terms between maternal asthma and each pollutant were included
to test the effect modification by asthma status. Interactions with a p < 0.05 were considered
significant. Models were adjusted for site and covariates from the medical record including
maternal age, race/ethnicity, pre-pregnancy body mass index, parity, marital status,
insurance, smoking and alcohol use during pregnancy. Site-adjusted crude models were
similar to fully adjusted models. Therefore, only fully adjusted models are presented.
Criteria air pollutants (PM10, PM2.5, O3, NOx, SO2, CO) and PM2.5 constituents were
analyzed in the continuous scale and relative risks were calculated for these pollutants based
on the interquartile range (IQR; the difference between the 25th and 75th percentile;
Supplemental Table 1). Since PAHs and VOCs were generally observed at very low levels
and the model results were not fused with existing monitor data, we chose to dichotomize
exposure at the 75th percentile to estimate risk associated with high exposure rather than
assume a linear model.

Author Manuscript

Sensitivity analyses were conducted restricting the dataset to nulliparous women who are
known to have higher preeclampsia risk. We also restricted the analyses to obese women
only and to normal weight women only to assess the potential impact of maternal weight on
our findings. Finally, we examined the subset of severe preeclampsia cases which may be
less likely to be impacted by air quality. All analyses were conducted using SAS version 9.4
(SAS Institute Inc., Cary, NC).

3. Results
As anticipated, maternal asthma was more common in pregnancies with preeclampsia (9%
versus 7%, Table 1). Women with preeclampsia were slightly younger, more likely to be
black, have higher BMI, and to be nulliparous. Smoking was less common in pregnancies
with preeclampsia for both asthmatics and non-asthmatics.

Author Manuscript

We observed significant interactions for NOx and SO2 in the first trimester and for elemental
carbon in the whole pregnancy average, with higher risk estimates among asthmatics (Table
2). Risks were significantly elevated 11% for asthmatics in association with whole
pregnancy elemental carbon exposure and 10% for second trimester CO exposure. Among
non-asthmatics, significant risk reductions were observed for first trimester NOx and SO2
exposure, with elevated risks associated with elemental carbon and organic compounds in
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the second trimester, sulfite particles in the first trimester and whole pregnancy dust
particles.

Author Manuscript
Author Manuscript

The interaction of VOCs and asthma (Table 3) reveals a fairly consistent pattern of increased
risk for asthmatics (6–70%) with significant interactions observed for most of the
compounds studied in multiple windows. Significantly increased risks (13–70%) for
asthmatics compared to non-asthmatics were seen in every time window studied for
benzene, ethylbenzene, m-xylene, o-xylene, p-xylene, and toluene. Risk estimates tended to
be higher for whole pregnancy average exposures for both asthmatics and non-asthmatics.
No interaction was observed for methyl-tertiary butyl ether, sesquiterpene or styrene.
Preeclampsia risk estimates were elevated for both asthmatics (39%) and non-asthmatics
(15%) in relation to second trimester benzene exposure and whole pregnancy exposure
increased risk for asthmatics only. Ethylbenzene increased preeclampsia risk in all time
windows (23–70%) among asthmatics but only whole pregnancy exposure significantly
increased risk for non-asthmatics. Cyclohexane increased risk for asthmatics in the first
trimester (19%) and whole pregnancy for asthmatics (31%) and non-asthmatics (8%). Nhexane was associated with increased risk for asthmatics in the second trimester (28%) and
whole pregnancy for asthmatics (54%) and non-asthmatics (28%). Methyl ethyl ketone
increased risk 23–24% for all pregnancy windows only among women with asthma. For mxylene and p-xylene, all windows had significantly elevated risks (20–62%) for asthmatics
but only whole pregnancy exposure increased risk for non-asthmatics (25–33%). The pattern
of preeclampsia risk was similar for o-xylene but the magnitude of increase was smaller than
with the other xylene compounds. Propene increased risk only for asthmatics in the first
trimester (15%) and after whole pregnancy exposure (17%). Sesquiterpene increased
preeclampsia risk for asthmatics (16%) after first trimester exposure and after second
trimester exposure in non-asthmatics (6%). Toluene in all pregnancy time windows
increased risk among asthmatics (31–38%) but only increased preeclampsia risk in nonasthmatics after second trimester exposure (14%).

Author Manuscript

PAH exposure had less of an impact on preeclampsia risk overall and interactions with
maternal asthma were less common (Table 4). Significant interactions were observed with
preconception fluoranthene and most windows for naphthalene were associated with
increased risk for asthmatics (11–21%) but no other compounds or windows differed by
asthma status. Elevated preeclampsia risk was observed for non-asthmatics associated with
acenaphthene second trimester and whole pregnancy exposure (6–7%) and for whole
pregnancy acenaphthylene (9%). Preconception anthracene was associated with 5%
increased preeclampsia risk in non-asthmatics. Preconception fluoranthene increased risk
15% for asthmatics and second trimester exposure increased risk 8% for non-asthmatics.
Fluorene in the second trimester and whole pregnancy increased risk 7–8% for nonasthmatics. Naphthalene increased risk for asthmatics in the second trimester and whole
pregnancy (21%) and whole pregnancy pyrene increased preeclampsia risk for nonasthmatics (7%).
Analyses restricted to nulliparous women, as well as those restricted by pre-pregnancy BMI
status to normal weight only and obese women only, generally yielded similar results as the
main analyses although with a loss of precision due to the smaller sample. Restriction to
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severe preeclampsia cases attenuated the results and several inverse associations were
observed (data not shown).

4. Discussion

Author Manuscript

We found first trimester exposure to NOx and SO2 and whole pregnancy elemental carbon
were associated with higher risks of preeclampsia among asthmatic women compared to
their non-asthmatic counterparts. SO2 has not been previously studied in relation to
preeclampsia alone, so our findings for this pollutant are novel. Most notably, nearly all the
VOCs we studied were associated with increased risk of preeclampsia, with significantly
higher risk in pregnancies complicated by maternal asthma. In our data, modeled VOC
exposure among asthmatics was associated with increased preeclampsia risk up to 70%. In
contrast, with the exception of naphthalene and fluoranthene, PAH exposures rarely
interacted with maternal asthma in relation to preeclampsia risk, but some PAHs were
associated with elevated risk in both groups.

Author Manuscript

A recent meta-analysis (Pedersen et al., 2014) found no significant effect of O3, CO, PM10,
or NOx on preeclampsia risk. Neither PM2.5 nor NO2 were associated with preeclampsia in a
recent study of similar size based on vital records in New York City (Savitz et al., 2015).
With regard to PM2.5, all time windows studied were null in our analyses, in contrast to the
30% increased risk estimated by Pederson and colleagues (Pedersen et al., 2014) but
consistent with the findings by Savitz and colleagues (Savitz et al., 2015). One prior paper
that controlled for maternal asthma found a 4% increase in preeclampsia after first trimester
exposure to ozone and no effect for NO2 in a Swedish registry-based study (Olsson et al.,
2013). In contrast, we observed no effect for ozone at any time window and no significant
interaction with asthma, although our first trimester relative risk of 1.03 is similar to the risk
estimates of 1.04–1.05 for ozone single-pollutant models reported by Olsson and colleagues
(Olsson et al., 2013).

Author Manuscript

A study based on a hospital cohort in Pittsburgh found no significant effect on preeclampsia
after first trimester exposure to PM2.5 or ozone measured using space/time kriging to
estimate zip code level exposures, although the point estimates were elevated (Lee et al.,
2013). Land use regression models were used in Western Australia to estimate NO2 as a
marker for traffic (Pereira et al., 2013) with a 30% increase in preeclampsia observed with
third trimester exposure and 12% increase with the whole pregnancy average. In Los
Angeles and Orange County, California, line-source dispersion models to estimate whole
pregnancy traffic exposures found a 33% increase in preeclampsia for NOx and 42%
increase in the highest quartile of PM2.5 (Wu et al., 2009). Building on that study, the
authors compared various exposure assessment methods and found some variation in risk by
both location and model choice with significant effects for ozone in Orange County and CO
in Los Angeles that were not consistently observed (Wu et al., 2011). CO has also been
associated with protective effects in a large Ontario, Canada study that linked birth records
to ambient monitoring data and observed a dose-response reduction in preeclampsia with a
nearly 50% reduction in the highest quartile of exposure (Zhai et al., 2012). In the only other
study that evaluated preconception time windows (Rudra et al., 2011), CO was associated
with a two-fold increased risk of preeclampsia in Washington State but no effect was
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observed for PM2.5. We observed a significant increase in risk for asthmatics (RR = 1.10)
associated with second trimester CO exposure.

Author Manuscript

Severity of preeclampsia is rarely studied and in our study, risk for severe preeclampsia was
not increased by air pollution. Two prior reports (Dadvand et al., 2013; Malmqvist et al.,
2013) have attempted to look at classifications of preeclampsia, either mild/severe or early/
late onset. Dadvand and colleagues (Dadvand et al., 2013) used spatio-temporal models of
PM, NO2 and NOx in Barcelona, Spain and found overall preeclampsia risk was increased
51% preeclampsia risk for third trimester PM2.5 and 39% increased risk for PM2.5
absorbance (a proxy for elemental carbon) but early onset preeclampsia was not associated
with air pollutants. We observed no effect of PM2.5 in our data, but we observed an effect for
elemental carbon in the second trimester for non-asthmatics, and a significant interaction
with maternal asthma and 11% increased risk for whole pregnancy exposure. We also
observed a significant interaction between maternal asthma and NOx in the first trimester
that suggests increased risk for preeclampsia among asthmatics. Somewhat similar findings
were seen in southern Sweden where traffic data was used to model NOx exposure and
significant effects were observed for both mild and severe preeclampsia across all trimesters
although the effects were more consistent for mild cases (Malmqvist et al., 2013). Also with
regard to traffic, the Barcelona group examined sources and found that brake dust and total
traffic exposure associated with PM10 appeared to increase preeclampsia risk (Dadvand et
al., 2014) but no associations with proximity to roadways was observed in Rotterdam (van
den Hooven et al., 2009).

Author Manuscript

Beyond elemental carbon, which was estimated in Barcelona (Dadvand et al., 2013), the
other constituents of PM2.5 have not been studied in relation to preeclampsia. We observed
increased risks in the second trimester for organic compounds and for dust particles as well
as elemental carbon. Whole pregnancy average dust was also associated with preeclampsia.
Significant interaction with asthma was only observed for whole pregnancy elemental
carbon exposure, with higher risks among asthmatics but the overall patterns of risk do not
suggest differential effects by asthma status.

Author Manuscript

Our novel results for VOC and PAH exposures were striking and we hope that they stimulate
further research in this area. Nearly all of the VOCs studied demonstrated a differential
effect with significantly higher risk among asthmatics than in the non-asthmatic group.
Risks were generally higher later in pregnancy or with whole pregnancy averages. The
interaction models revealed increased risks for asthmatic mothers for many compounds at all
time points studied suggesting a more persistent vulnerability for women with asthma. With
regard to PAH exposure, increased risks were less common and tended to be of smaller
magnitude than those observed for VOCs. Second trimester and/or whole pregnancy average
exposures were associated with preeclampsia for acenaphthene, acenaphthylene,
fluoranthene, fluorene, and pyrene. Interaction with maternal asthma was also less common
for ambient PAH exposure, with the exception of naphthalene and fluoranthene. These
findings merit further attention both in ambient exposure studies as well as in occupational
settings.
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The literature is exceedingly sparse for VOC exposure and either preeclampsia or
hypertension. VOC exposure is most commonly related to new carpets, adhesives,
upholstery, manufactured wood or leather goods, and in some pesticides or cleaning fluids.
Cigarette smoke is also a major source of benzene exposure. Exposure to benzene has been
associated impaired pregnancy maintenance in both human and animal studies (Cummings
and Kavlock, 2004). On the other hand, tap water exposure to benzene did not increase
hypertension in a US population (Burg and Gist, 1998). A worker exposed to high levels of
methyl ethyl ketone and toluene from adhesive vapor became ill with symptoms that
included elevated blood pressure (Mills et al., 2012). High levels of toluene appear to raise
blood pressure (Chang et al., 2010; Capron and Logan, 2009), but lower levels may not
(Chang et al., 2010). We have also previously found that acute exposure to several VOCs
and some PAHs elevate blood pressure among women with new onset hypertensive disorders
of pregnancy (Mannisto et al., 2014). Our findings at very low ambient exposure levels
among pregnant women, particularly those with asthma, merit further attention both in
ambient exposure studies as well as in occupational settings.
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Our study is limited by the use of the hospital referral region as the geographic unit for our
exposure time-windows. Women may move during pregnancy, so the earlier time windows
in particular may suffer from misclassification of exposure. On the other hand, averaging
over the hospital referral region will capture some local mobility as well as indicate average
exposure for most of the cohort who are likely to live within the referral region of their
delivery hospital. In addition, because air pollution is regulated at the population level,
studies identifying regional-level air pollution levels that are associated with increased risk
for preeclampsia will be informative for regulatory and public health agencies. We also
adjust all of our analyses for study site as a way to control for potential differences in
medical record recording and other unmeasured factors, but site also explains some of the
variance in air pollutants, making our estimates somewhat conservative. For some time
windows, we observed inverse associations between pollutants and preeclampsia. We do not
anticipate increases in air pollution exposure to biologically confer protection but they may
be chance findings or related to the negative correlations among pollutants. We did not
adjust our findings for multiple comparisons because of the exploratory nature of the
analyses (Rothman, 1990) but the number of significant interactions with maternal asthma
suggests a pattern of findings above chance. Finally, we recognize that although the
intrapartum electronic medical records provide rich clinical data, we did not have access to
the specific week in gestation when preeclampsia was diagnosed, asthma severity or
treatment which could have impacted our findings. As such, we used the severe
preeclampsia diagnosis as a marker of early onset and note that a diagnosis will often trigger
a medically indicated delivery within a relatively short time frame. We also assume our
findings represent the experience of the average asthma patient and those with more severe
disease could have a more complicated course.
The strengths of our study include detailed exposure models which account for weather and
have both temporal and spatial dispersion with multiple sites across the US over an 8-year
period. The large, contemporary, obstetric database allows us to control for detailed clinical
data that are not available or unreliably reported in administrative sources such as birth
certificates or insurance data.
Environ Res. Author manuscript; available in PMC 2017 July 01.
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5. Conclusions
This is the first study to comprehensively study the interaction of maternal asthma, a
common chronic disease in contemporary obstetric practice known to increase preeclampsia
risk, and air pollutant exposures. We find many exposures that differentially increase
preeclampsia risk for women with asthma, suggesting they are a particularly vulnerable
population.

Author Manuscript

Consistent with a recent meta-analysis of preeclampsia, we found no effect for most criteria
air pollutants on preeclampsia risk with the exception of a 10% increased risk among
asthmatics associated with second trimester CO exposure. We also observed few interactions
with maternal asthma for the commonly measured criteria air pollutants with the exception
of first trimester NOx and SO2. In contrast, we see a strong signal for most VOC exposures,
particularly for women with asthma. These results merit further investigation and suggest
that women with asthma, who already experience higher rates of preeclampsia, may be a
vulnerable subpopulation with respect to air pollution exposure.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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PM2.5

Particulate Matter < 2.5 µm

NO2

nitrogen dioxide

NOx

nitrogen oxides

PM10

Particulate Matter < 10 µm

CO

carbon monoxide

O3

ozone
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PAHs

polycyclic aromatic hydrocarbons

VOCs

volatile organic compounds

ICD-9

International Classification of Diseases, Ninth Revision

CMAQ

Community Multiscale Air Quality

IQR

interquartile range

BMI

body mass index
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22,987 (92.1)
11,551 (82.8)
3171 (83.3)

5332 (7.6)
5739 (6.9)
4,522 (7.0)
4528 (7.3)
6492 (5.2)
7591 (9.7)
706 (10.6)
7767 (6.6)
6121 (9.1)
901 (3.6)
1813 (13.0)
463 (12.2)

Unknown
Nulliparous
Primiparous
Multiparous
Married
Not married

Environ Res. Author manuscript; available in PMC 2017 July 01.
Unknown
Private
Public
Self-pay, other, or unknown

Smoking during pregnancy, n (%)

Alcohol use during pregnancy, n (%)

Insurance status, n (%)

Marital status, n (%)

Parity, n (%)

57,331 (85.5)

104,873 (88.5)

5637 (84.7)

66,944 (85.5)

112,610 (90.4)

55,292 (89.2)

58,345 (89.7)

71,554 (85.8)

60,933 (86.4)

19,964 (82.0)

27,462 (87.6)

2301 (7.3)
2450 (10.1)

69,689 (91.1)

7143 (91.7)

12,325 (89.0)

8395 (93.7)

33,159 (89.8)

37,963 (83.2)

Obese

436 (5.6)

825 (6.0)

Other/Unknown

4270 (5.6)

188 (2.1)

Asian/Pacific Islander

Normal weight

2028 (5.5)

Hispanic

Underweight

4556 (10.0)

Black

25 (0.7)

89 (0.6)

58 (0.2)

365 (0.5)

495 (0.4)

43 (0.7)

532 (0.7)

386 (0.3)

198 (0.3)

182 (0.3)

538 (0.7)

370 (0.5)

228 (0.9)

131 (0.4)

179 (0.2)

10 (0.1)

56 (0.4)

10 (0.1)

115 (0.3)

314 (0.7)

423 (0.4)

26.2 (6.8)

27.6 (6.1)
93,349 (88.8)

26.1 (6.1)
7192 (6.8)

Asthma n = 918

No asthma n = 185,191

Asthma n = 14,789

White

n = 10,528

n = 199,980

Overweight

Pre-pregnancy BMI, n (%)

Race, n (%)

Age, mean (SD)

Preeclampsia

Normotensive

148 (3.9)

502 (3.6)

1011 (4.1)

3234 (4.8)

5365 (4.5)

268 (4.0)

3234 (4.1)

5020 (4.0)

2007 (3.2)

2016 (3.1)

5587 (6.7)

3863 (5.5)

1699 (7.0)

1470 (4.7)

2379 (3.1)

199 (2.6)

648 (4.7)

371 (4.1)

1616 (4.4)

2799 (6.1)

4176 (4.0)

27.2 (6.6)

No asthma n = 9610

Descriptive statistics by preeclampsia and asthma status, Consortium on Safe Labor/Air Quality and Reproductive Health Study, 2002–2008 (N =
210,508).
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Dust particles

Sulfite particles

Organic compounds

Nitrate particles

Ammonium particles

Elemental carbon

PM2.5 constituents

PM2.5

PM10

SO2

O3

NOX

CO

1.03 (0.93–1.14)
1.02 (0.98–1.05)
1.05 (0.96–1.15)
1.02 (0.98–1.06)
0.95 (0.87–1.04)
0.99 (0.96–1.03)
0.99 (0.92–1.06)
1.02 (0.98–1.06)

No asthma
Asthma
No asthma
Asthma
No asthma
Asthma
No asthma

0.97 (0.93–1.02)

No asthma

1.02 (0.98–1.07)

0.95 (0.85–1.07)

Asthma

Asthma

0.98 (0.95–1.02)

No asthma

No asthma

0.91 (0.83–1.00)

Asthma

0.99 (0.89–1.11)

0.98 (0.94–1.01)

No asthma

1.02 (0.98–1.06)

1.04 (0.96–1.13)

Asthma

Asthma

1.01 (0.97–1.05)

No asthma

No asthma

1.03 (0.93–1.14)

Asthma

1.06 (0.97–1.16)

0.98 (0.94–1.03)

No asthma

Asthma

1.05 (0.94–1.16)

0.99 (0.95–1.03)

Asthma

1.03 (0.94–1.13)

No asthma

1.03 (0.99–1.06)

1.03 (0.95–1.10)

1.07 (1.00–1.15)

1.05 (0.93–1.18)

0.96 (0.91–1.02)

1.05 (0.93–1.19)

0.96 (0.93–0.99)

1.06 (0.96–1.17)

0.96 (0.88–1.05)

1.03 (0.88–1.21)

0.98 (0.93–1.03)

1.06 (0.95–1.18)

0.99 (0.94–1.04)

1.03 (0.93–1.16)

1.03 (0.99–1.06)

1.02 (0.94–1.12)

1.06 (1.02–1.10)

1.03 (0.96–1.10)

0.95 (0.88–1.01)

0.92 (0.82–1.03)

1.09 (1.03–1.16)

1.08 (0.95–1.22)

1.02 (0.98–1.05)

1.05 (0.95–1.15)

1.03 (0.93–1.13)

1.01 (0.87–1.19)

1.05 (1.00–1.10)

1.10 (0.99–1.22)

0.99 (0.95–1.04)

1.01 (0.91–1.13)

1.02 (0.99–1.06)

0.99 (0.90–1.08)

1.00 (0.97–1.03)

1.05 (0.98–1.13)

1.02 (0.94–1.11)c
0.93 (0.90–0.97)

0.96 (0.93–1.00)

1.00 (0.90–1.10)

0.98 (0.94–1.03)

1.07 (0.96–1.20)

1.01 (0.97–1.04)

1.10 (1.00–1.20)

RR (95% CI)

Second trimester

1.03 (0.99–1.06)

0.99 (0.89–1.09)

0.94 (0.90–0.98)

1.05 (0.95–1.17)c

0.96 (0.93–1.00)

1.03 (0.93–1.13)

RR (95% CI)

RR (95% CI)
Asthma

First trimester

Preconception

1.07 (1.02–1.12)

1.04 (0.97–1.12)

1.01 (0.93–1.09)

0.99 (0.87–1.12)

1.02 (0.96–1.08)

1.09 (0.98–1.21)

0.99 (0.95–1.05)

1.05 (0.95–1.17)

1.03 (0.96–1.09)

1.06 (0.93–1.20)

1.03 (0.99–1.06)

1.11 (1.03–1.21)c

1.02 (0.94–1.11)

1.07 (0.93–1.24)

1.04 (0.99–1.08)

1.01 (0.93–1.10)

0.98 (0.92–1.05)

1.06 (0.96–1.17)

0.95 (0.91–1.01)

0.98 (0.88–1.09)

0.97 (0.89–1.04)

1.06 (0.94–1.20)

1.01 (0.96–1.05)

1.08 (0.99–1.18)

RR (95% CI)

Whole pregnancy

Adjusteda risk ratios (and 95% confidence intervals) for preeclampsia per IQR unit increaseb in pollutant by exposure window and asthma status,
Consortium on Safe Labor/Air Quality and Reproductive Health Study, 2002–2008 (N = 210,508).
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Distributions and IQRs are shown in Supplemental Table 1.

c
Estimates in bold indicate significant interaction between pollutant and maternal asthma p < 0.05.

b

Models are adjusted for maternal race/ethnicity, age, parity, pre-pregnancy BMI, smoking and alcohol use, insurance status, marital status and study site. The estimates are based on the interaction of
maternal asthma and each pollutant derived from a single model, not stratified analyses.
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Sesquiterpene

Propene

P-xylene

O-xylene

M-xylene

Methyl ethyl ketone

N-hexane

Methyl-tertiary butyl ether

Cyclohexane

Ethylbenzene

1,3-Butadiene

Benzene

1.12 (0.97–1.30)
1.05 (0.99–1.11)

No asthma

0.99 (0.95–1.04)

Asthma

No asthma

1.01 (0.96–1.07)

1.16 (1.00–1.35)

1.06 (1.00–1.12)

1.02 (0.88–1.19)

0.99 (0.94–1.04)

1.08 (0.93–1.24)

0.98 (0.94–1.03)

1.02 (0.90–1.16)

1.09 (0.98–1.21)

No asthma

1.22 (1.02–1.47)c

1.15 (1.00–1.33)c

1.20 (1.00–1.44)c

1.28 (1.08–1.52)c

Asthma

1.19 (1.04–1.35)

1.41 (1.17–1.70)c

1.11 (0.97–1.27)

1.34 (1.11–1.62)c

0.97 (0.92–1.03)

0.97 (0.86–1.10)

0.94 (0.82–1.08)

0.91 (0.79–1.05)

No asthma

0.93 (0.80–1.08)

1.18 (0.96–1.43)c

Asthma

1.00 (0.87–1.16)

1.16 (0.95–1.41)c

No asthma
1.01 (0.87–1.17)

1.23 (1.01–1.51)c

1.22 (1.00–1.50)c

Asthma

Asthma

0.97 (0.92–1.03)

0.96 (0.91–1.01)

1.24 (1.06–1.44)c

1.24 (1.07–1.44)c

No asthma

1.05 (0.96–1.14)

0.95 (0.88–1.03)

1.28 (1.08–1.51)c

1.02 (0.87–1.18)

1.03 (0.95–1.12)

No asthma

1.00 (0.94–1.05)

1.16 (0.98–1.36)c

1.14 (0.98–1.33)

0.99 (0.92–1.06)

1.14 (0.98–1.33)

1.06 (0.93–1.22)

1.26 (1.04–1.53)c

1.03 (0.96–1.11)

1.00 (0.95–1.05)

1.09 (0.94–1.27)

Asthma

1.17 (0.99–1.38)

Asthma

1.01 (0.96–1.06)

0.89 (0.83–0.97)

No asthma

No asthma

1.19 (1.02–1.39)c

1.13 (0.96–1.32)c

Asthma
0.99 (0.92–1.06)

0.99 (0.87–1.13)

1.09 (0.95–1.26)

No asthma

1.04 (0.89–1.21)

1.23 (1.02–1.49)c

1.30 (1.07–1.58)c

Asthma

1.02 (0.96–1.09)

1.02 (0.96–1.08)

1.02 (0.87–1.19)

Asthma

No asthma

1.15 (1.04–1.27)

1.06 (0.91–1.23)c

0.98 (0.89–1.07)

No asthma

1.39 (1.16–1.65)c

RR (95% CI)

Second trimester

0.87 (0.80–0.95)

1.13 (0.95–1.34)c

1.16 (0.98–1.38)c

Asthma

0.99 (0.85–1.16)

RR (95%CI)

RR (95% CI)

Asthma

First trimester

Preconception

0.99 (0.92–1.06)

1.06 (0.90–1.23)

0.99 (0.93–1.04)

1.17 (1.01–1.36)c

1.33 (1.17–1.49)

1.62 (1.35–1.95)c

1.11 (0.96–1.28)

1.38 (1.14–1.68)c

1.25 (1.11–1.41)

1.56 (1.29–1.87)c

0.98 (0.91–1.05)

1.23 (1.05–1.44)c

1.28 (1.05–1.55)

1.54 (1.20–1.97)c

0.99 (0.94–1.05)

1.11 (0.96–1.30)

1.08 (1.00–1.18)

1.31 (1.11–1.54)c

1.42 (1.26–1.61)

1.70 (1.42–2.04)c

1.03 (0.96–1.10)

0.98 (0.84–1.15)

1.18 (0.97–1.44)

1.43 (1.11–1.83)c

RR (95% CI)

Whole pregnancy

Adjusteda risk ratios (and 95% confidence intervals) for preeclampsia associated with high exposureb to volatile organic compounds by exposure window
and asthma status, Consortium on Safe Labor/Air Quality and Reproductive Health Study, 2002–2008 (n = 210,508).
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Toluene

1.31 (1.08–1.59)c

1.17 (0.97–1.41)c
0.91 (0.80–1.04)

No asthma
1.07 (0.93–1.22)

1.06 (0.99–1.12)

1.02 (0.97–1.09)

No asthma

1.04 (0.89–1.21)

Asthma

0.96 (0.83–1.11)

Asthma

1.14 (1.00–1.30)

1.38 (1.15–1.66)c

1.03 (0.97–1.11)

0.97 (0.82–1.13)

RR (95% CI)

1.10 (0.96–1.26)

1.36 (1.12–1.66)c

1.01 (0.94–1.08)

0.95 (0.81–1.12)

RR (95% CI)

Whole pregnancy

c
Estimates in bold indicate significant interaction between pollutant and maternal asthma p < 0.05.

Distributions are shown in Supplemental Table 1. Pollutant levels were dichotomized at the 75th percentile and high exposure is that upper quartile compared to the rest of the distribution.

b

Models are adjusted for maternal race/ethnicity, age, parity, pre-pregnancy BMI, smoking and alcohol use, insurance status, marital status and study site. The estimates are based on the interaction of
maternal asthma and each pollutant derived from a single model, not stratified analyses.

a

Author Manuscript

Styrene

RR (95%CI)

Author Manuscript
RR (95% CI)

Second trimester

Author Manuscript

First trimester

Author Manuscript

Preconception
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1.12 (0.97–1.29)
0.99 (0.94–1.04)

No asthma

1.00 (0.95–1.05)

Asthma

No asthma

0.97 (0.92–1.03)

1.06 (0.91–1.22)

0.95 (0.91–1.00)

1.03 (0.90–1.18)

0.90 (0.83–0.98)

0.91 (0.84–0.99)

No asthma
1.07 (0.94–1.22)

1.04 (0.90–1.20)

1.12 (0.96–1.29)c

Asthma

0.97 (0.92–1.01)

0.96 (0.92–1.01)

No asthma

1.01 (0.88–1.16)

0.97 (0.92–1.02)

Asthma

1.07 (0.93–1.22)

1.01 (0.96–1.06)

Asthma

No asthma

1.09 (0.95–1.25)

0.97 (0.92–1.03)

1.00 (0.95–1.05)

No asthma
1.05 (0.92–1.20)

1.07 (0.93–1.23)

1.15 (1.01–1.32)c

Asthma

Asthma

0.96 (0.92–1.01)

0.95 (0.91–1.00)

1.07 (0.93–1.22)

1.04 (0.91–1.18)

0.96 (0.92–1.01)

1.01 (0.88–1.15)

No asthma

0.97 (0.92–1.02)

0.98 (0.94–1.03)

1.12 (0.97–1.29)

1.02 (0.97–1.07)

1.04 (0.91–1.18)

0.99 (0.93–1.04)

1.13 (0.99–1.29)

0.97 (0.92–1.02)

1.10 (0.96–1.26)

Asthma

1.07 (0.93–1.22)

No asthma

1.02 (0.97–1.07)

Asthma

0.90 (0.78–1.05)

No asthma

1.05 (1.00–1.10)

Asthma

0.95 (0.83–1.08)

No asthma

0.99 (0.93–1.04)

Asthma

1.04 (0.91–1.19)

No asthma

1.00 (0.95–1.05)

No asthma
Asthma

1.05 (0.91–1.20)

Asthma

RR (95% CI)

RR (95% CI)

1.04 (0.99–1.10)

1.05 (0.91–1.22)

1.04 (0.99–1.09)

1.02 (0.89–1.17)

1.04 (0.96–1.11)

1.21 (1.05–1.40)c

0.97 (0.93–1.02)

0.94 (0.82–1.08)

1.07 (1.02–1.12)

1.08 (0.94–1.24)

1.08 (1.03–1.14)

1.07 (0.93–1.23)

1.01 (0.96–1.07)

1.03 (0.90–1.19)

0.99 (0.94–1.03)

0.95 (0.83–1.09)

0.95 (0.90–1.00)

1.07 (0.93–1.24)

0.98 (0.94–1.03)

1.00 (0.87–1.14)

1.05 (0.99–1.10)

1.05 (0.92–1.20)

1.06 (1.01–1.11)

1.08 (0.94–1.25)

RR (95% CI)

Second trimester

1.07 (1.00–1.14)

1.15 (0.99–1.33)

0.99 (0.95–1.04)

1.06 (0.93–1.21)

0.96 (0.88–1.06)

1.21 (1.04–1.42)c

0.98 (0.93–1.03)

1.02 (0.89–1.17)

1.08 (1.02–1.14)

1.06 (0.93–1.22)

1.02 (0.96–1.07)

1.11 (0.96–1.27)

0.99 (0.94–1.04)

0.99 (0.87–1.13)

1.04 (0.99–1.09)

1.03 (0.90–1.18)

0.99 (0.94–1.04)

1.09 (0.94–1.26)

1.04 (0.98–1.10)

1.09 (0.95–1.25)

1.09 (1.03–1.16)

1.03 (0.90–1.19)

1.07 (1.01–1.13)

1.03 (0.89–1.18)

RR (95% CI)

Whole pregnancy

Models are adjusted for maternal race/ethnicity, age, parity, pre-pregnancy BMI, smoking and alcohol use, insurance status, marital status and study site. The estimates are based on the interaction of
maternal asthma and each pollutant derived from a single model, not stratified analyses.

a

Pyrene

Phenanthrene

Naphthalene

Ideno[1,2,3-Cd]pyrene

Fluorene

Fluoranthene

Chrysene

Benzo[a]-pyrene

Benzo[a]-anthracene

Anthracene

Acenaphthylene

Acenaphthene

First trimester

Preconception

Adjusteda risk ratios (and 95% confidence intervals) for preeclampsia associated with high exposureb to polycyclic aromatic hydrocarbons by exposure
window and asthma status, Consortium on Safe Labor/Air Quality and Reproductive Health Study, 2002–2008 (N = 210,508).
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c
Estimates in bold indicate significant interaction between pollutant and maternal asthma p < 0.05.

Distributions are shown in Supplemental Table 1. Pollutant levels were dichotomized at the 75th percentile and high exposure is that upper quartile compared to the rest of the distribution.
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